A detailed history of Armistice Capital, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 7,276,000 shares of CTXR stock, worth $21.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,276,000
Previous 10,156,000 28.36%
Holding current value
$21.2 Million
Previous $5.89 Million 38.23%
% of portfolio
0.06%
Previous 0.08%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.48 - $1.02 $1.38 Million - $2.94 Million
-2,880,000 Reduced 28.36%
7,276,000 $3.64 Million
Q2 2024

Aug 14, 2024

BUY
$0.58 - $1.03 $5.89 Million - $10.5 Million
10,156,000 New
10,156,000 $5.89 Million
Q4 2019

Feb 14, 2020

SELL
$0.42 - $1.15 $922,901 - $2.53 Million
-2,197,385 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$0.72 - $1.38 $1.58 Million - $3.03 Million
2,197,385 New
2,197,385 $2.47 Million
Q1 2019

May 15, 2019

SELL
$0.86 - $1.53 $635,050 - $1.13 Million
-738,431 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.99 - $1.89 $673,200 - $1.29 Million
680,000 Added 1163.77%
738,431 $768,000
Q3 2018

Nov 14, 2018

BUY
$1.14 - $3.09 $66,611 - $180,551
58,431 New
58,431 $100,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $425M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.